研究表明较高的体重指数（BMI）与肾功能快速下降的风险升高显著相关1。体重调整腰围指数 (WWI) 是比BMI更稳健的内脏型肥胖指标。横断面研究表明，WWI与慢性肾脏病 (CKD) 患病率增加相关。然而，该结论缺乏决定性的纵向研究结果。

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...

随着糖尿病患病人数剧增，肾脏作为重要靶器官，损害也随之增多，如何优化糖尿病相关慢性肾脏病（CKD）的管理成为目前临床重点关注的问题之一。非奈利酮是全球首个新型非甾体盐皮质激素受体拮抗剂（nsMRA），已被国内外多项权威指南推荐作为2型糖尿病（T2DM ...

Smoking increases the likelihood of developing numerous morbidities; however, it remains unclear how this behavior may impact ...

The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.

但慢性肾脏病患者由于肾脏排泄功能减弱,无法有效清除蛋白质代谢产生的含氮废物,导致这些废物在体内蓄积,加重肾脏负担。

Gestational exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk for childhood ...

CKD-510 is under development for the treatment of Charcot-Marie-Tooth disease and atrial fibrillation. It is administered through oral route.The drug candidate is a new chemical entity targeting ...